Mannkind Corporation (MNKD) Oversold Based on One IndicatorMark Melin
As the stock of MannKind Corporation (NASDAQ:MNKD) tumbled Wednesday and Thursday, outpacing general stock market declines, while a Forbes report, citing a technical indicator, says it is oversold and might be time for a bounce back.
MannKind's new wonder drug is a dud: Tourbillon
MannKind Corporation (NASDAQ:MNKD) had been the subject of short speculation from the hedge fund Tourbillon Capital Partners, first exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible